CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 115 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01268514
NCT01268514N/ACompleted

ENHANCE: A Prospective Long-term EvaluatioN of the Use of Permacol™ Biological Implant in tHe Repair of Complex AbdomiNal Wall CasEs

Medtronic - MITG·observational·Posted Dec 31, 2010·Updated May 10, 2024

In Brief

An observational study for Hernia, Abdominal and Abdominal Injuries. Completed, enrolled 115 participants across 12 sites in 5 countries.

Detailed Summary

The objective of this prospective study is to evaluate short-term, mid-term, and long-term clinical outcomes associated with the use of Permacol™ Biological Implant in the treatment of complex abdominal wall defects

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesBelgium, Germany, Italy, Luxembourg, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedDec 31, 2010
Enrollment StartFeb 1, 2011
Primary CompletionNov 1, 2016
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 15.5 years ago